Related Experiment Video
Updated: Sep 29, 2025

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Phospho-SIM and exon8b of PML protein regulate formation of doxorubicin-induced rDNA-PML compartment
Terezie Hornofova1, Barbora Pokorna1, Sona Stemberkova Hubackova1
1Laboratory of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague 142 20, Czech Republic.
Abstract:
Repetitive sequences are among the most unstable regions in the eukaryotic genome and defects in their maintenance correlate with premature aging and cancer development. Promyelocytic leukemia protein (PML) induces accumulation of proteins at distinct nuclear sites, thereby affecting a plethora of processes including DNA repair or maintenance of telomeres. Doxorubicin, the broadly used chemotherapeutic compound, induces formation of PML-nucleolar associations (PNAs). Nevertheless, molecular factors affecting formation of PNAs are still largely unknown. Here we show that PNAs can accumulate ribosomal DNA (rDNA) and, after restoration of RNA polymerase I activity, these structures transfer a fraction of rDNA outside the nucleolus. Mutagenesis of PML isoforms revealed that this process depends on the SUMO-interacting motif and adjacent serine-rich region, and is enhanced by exon8b present exclusively in PML IV isoform. Moreover, we demonstrate that PNAs formation is also regulated by p14ARF/p53 tumor suppressors and casein kinase 2. Our data elucidate how PML nucleolar compartment is assembled, bring the first evidence of PML interacting with rDNA, and show the PML-dependent translocation of rDNA away from the nucleolus.
Insights
Promyelocytic leukemia protein (PML) forms nuclear structures that bind and relocate ribosomal DNA (rDNA) from the nucleolus. This process, influenced by PML structure and other factors, offers insights into genome stability and cancer research.
Area of Science:
- Genetics and Epigenetics
- Molecular Biology
- Cellular Biology
Background:
- Repetitive genomic sequences are prone to instability, with maintenance defects linked to aging and cancer.
- Promyelocytic leukemia protein (PML) organizes nuclear protein clusters, impacting DNA repair and telomere maintenance.
- Doxorubicin induces PML-nucleolar associations (PNAs), but the molecular regulation of PNA formation remains unclear.
Purpose of the Study:
- To investigate the molecular factors and mechanisms governing the formation and function of PML-nucleolar associations (PNAs).
- To explore the interaction between PML and ribosomal DNA (rDNA) within the nucleolus.
- To elucidate the role of PML isoforms and regulatory proteins in rDNA translocation.
Main Methods:
- Analysis of PML-nucleolar associations (PNAs) in response to doxorubicin treatment.
- Mutagenesis studies of PML isoforms to identify critical functional domains.
- Investigation of the role of SUMO-interacting motifs, serine-rich regions, and specific PML exons.
- Assessment of regulatory roles for p14ARF/p53 tumor suppressors and casein kinase 2.
Main Results:
- PNAs were found to accumulate ribosomal DNA (rDNA).
- PML-dependent transfer of rDNA outside the nucleolus was observed upon restoration of RNA polymerase I activity.
- PNA formation and rDNA translocation depend on PML's SUMO-interacting motif, serine-rich region, and exon8b (PML IV).
- p14ARF/p53 tumor suppressors and casein kinase 2 regulate PNA formation.
Conclusions:
- The study elucidates the assembly mechanism of the PML nucleolar compartment.
- Provides the first evidence of PML interacting with rDNA.
- Demonstrates PML-dependent translocation of rDNA away from the nucleolus, contributing to understanding genome stability mechanisms.
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Abnormal Proliferation
Negative Regulator Molecules
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...

